Lymphatic Drainage of the Breast, a Retrospective Assessment of Data
NCT ID: NCT05064215
Last Updated: 2021-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2021-05-25
2021-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Hematoma Following Breast Surgery
NCT03515525
Lymphedema Prevention in Breast Cancer
NCT04112966
Effect of Early Removal of Wound Drains After Mastectomy or Lymph Node Dissection
NCT03104153
Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema
NCT03210311
Manual Lymphatic Drainage in the Superior Member in Women in Post-surgery for Breast Cancer
NCT02475174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
injection behind NAC
in 7 breasts dye was injected behind the nipple areola complex before breast reduction
anatomical examination
After injection of dye, its distribution along lymphatic clearance paths was investigated
Injection into lateral upper quadrant
in 5 breasts dye was injected into upper lateral glandular tissue before breast reduction
anatomical examination
After injection of dye, its distribution along lymphatic clearance paths was investigated
injection into medial upper quadrant
in 2 breasts dye was injected into upper medial glandular tissue before breast reduction
anatomical examination
After injection of dye, its distribution along lymphatic clearance paths was investigated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
anatomical examination
After injection of dye, its distribution along lymphatic clearance paths was investigated
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
20 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Elisabeth Würinger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Elisabeth Würinger
Dr. Elisabeth Würinger
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisabeth Würinger
Role: PRINCIPAL_INVESTIGATOR
Dr. Elisabeth Würinger
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elisabeth Wuringer
Vienna, Österreich, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 21-102-VK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.